ECU
TMDX icon

Eisler Capital (US)’s Transmedics TMDX Stock Holding History

Eisler Capital (US)’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-9,662
Closed -$714K – 683
2024
Q1 		$714K Buy
+9,662
New +$796K 0.02% 431

Other funds holding TMDX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Eisler Capital (US)'s TMDX Position: Q2 2024 in Review

Eisler Capital (US) sold out of Transmedics (TMDX) in Q2 2024, closing a stake of 9,662 shares — an estimated $714K sold.

Eisler Capital (US) first reported a position in TMDX in Q1 2024 and held it in 1 quarter. The position peaked at $714K in Q1 2024. 340 funds tracked by Wall St. Rank hold TMDX as of Q2 2024.

  • Eisler Capital (US) reported no remaining Transmedics position as of Q2 2024 after selling out during the quarter.
  • Eisler Capital (US) sold 9,662 Transmedics shares in Q2 2024, an estimated $714K.
  • Eisler Capital (US) first reported a position in Transmedics in Q1 2024 and held it in 1 quarter.
  • Eisler Capital (US)'s Transmedics position peaked at $714K in Q1 2024.
  • 340 funds tracked by Wall St. Rank held Transmedics as of Q2 2024.

Based on Eisler Capital (US)'s 13F filing for Q2 2024, filed 13 Aug 2024.